Anat Shnaiderman, QA Manager
Brings over 15 years of QA and GMP experience in cell therapy and biologics. Previously held roles at BrainStorm Cell Therapeutics (NASDAQ: BCLI), Teva Pharmaceuticals (NYSE: TEVA), and Cognate BioServices (acquired by Charles River Laboratories, NYSE: CRL). She holds an M.Sc. in Medical Sciences and a B.Sc. in Biology from Tel Aviv University.
Hadas Shoham Nissan, Director Clinical and Regulatory affairs
With over 15 years of experience in cell and gene therapy, spanning clinical, regulatory, and business aspects. Previously with Emendo and Gamida Cell (NASDAQ: GMDA), she holds an M.Sc. in Medical Research and an M.B.A. in Finance & Marketing from the Hebrew University.
Gil Hakim, CEO
With over 20 years of experience in life sciences, specializing in early-stage innovation and market strategy. Previously with Urogen Pharma (NASDAQ: URGN), he holds a B.Sc. in Life Sciences from Ben-Gurion University.
Sigal Russo, CFO
With over 16 years of financial experience in biotech and pharmaceuticals. Previously with OWC Pharma (OTCQB: OWCP) and Rosetta Genomics (NASDAQ: ROSG), she holds a B.A. in Economics and Accounting from Ruppin Academic College.
Tal Ben Neriah, VP Operations
A leader in biotechnology operations with expertise in regenerative medicine and product development. Previously with CollPlant (NASDAQ: CLGN), she holds an M.Sc. in Materials Engineering & Nanotechnology from Tel Aviv University.
Tamar Harel Adar, PhD – VP R&D
An expert in biotechnology with experience at CollPlant (NASDAQ: CLGN) and Cellect (NASDAQ: APOP). She holds a Ph.D. in Biotechnology Engineering from Ben-Gurion University.
Member of the ‘Best Practice Task Force’ focused on the standardization of iPSC-based therapy, led by ISSCR (International Society for Stem Cell Medicine)
Alon Sinai, PhD – Co-Founder, Deputy CEO & President
With over 25 years of experience in medical operations and biotech, previously with LBT Laser Beam Therapeutics, he holds a Ph.D. in Health Systems Management from Ben-Gurion University.
Prof. Tal Dvir, PhD – Co-Founder & CSO
A pioneer in regenerative medicine, trained at MIT under Prof. Robert Langer. He founded Tel Aviv University’s Tissue Engineering Lab and leads research in nanotechnology-based tissue regeneration.
An award-winning researcher and recipient of the Young and Promising Bio-Medical Researcher Rappaport Prize (2018), the Juludan Foundation Research Award (2018), and the Da Vinci Award (2023).